Compare ARK Genomic Revolution ETF (ARKG) vs Banco Santander SA (SAN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Banco Santander SA — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Banco Santander SA trades at $13.75 (market cap $197.91B). The key difference: Banco Santander SA pays a 2.01% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | SAN | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $14.37 |
52-Week Low | $23.09 | $8.31 |
Market Cap | — | $197.91B |
Dividend Yield | — | 2.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Banco Santander (SAN) trades at $13.87, up 0.58% today, with a bullish technical signal from moving averages. The company reported $14.10B net income for 2025 with a 23.49% margin, though recent quarterly EPS results missed expectations. Analyst consensus is 64% buy, supported by news of Santander becoming Spain's most valuable company and its AI-driven efficiency initiatives.
Outlook is cautiously optimistic with strong profitability and strategic acquisitions, but risks include consecutive EPS misses, a significant net cash outflow trend, and regulatory scrutiny in Spain. The stock's valuation appears reasonable with a P/E of 13.78, offering potential upside if operational improvements materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →
